Clinical Trial Update: Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet [Phase 3]

View source ↗

Summary

Phase 3 study evaluating Phenoptin to increase phenylalanine tolerance in children with phenylketonuria on a restricted diet has completed, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• Phenoptin

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonurias | Phase 3 | Status: COMPLETED | Results posted: 2009-07-09